TopSpin gets FDA nod to begin US intravascular MRI (magnetic resonance imaging) catheter trials
This article was originally published in Clinica
The US FDA has given TopSpin Medical the green light to test in clinical trials a miniaturised MRI catheter that can characterise lipid-rich lesions from inside the coronary arteries.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.